
PHAOS TECHNOLOGY HOLDINGS-A
POASNYSE AMERICANTrading Snapshot
- Day Range
- $0.20 β $0.20
- 52-Week Range
- $0.17 β $7.40
- Volume
- $1.90B
- Avg Volume
- $2.53B
- Shares Outstanding
- 13.7M
- Next Earnings
- Sep 2, 2026
Fundamentals Snapshot
- Annual Revenue
- $167,707
- Last Q Revenue
- $68,083
- P/E Ratio
- -0.7
- P/S Ratio
- 20.8x
- EPS (TTM)
- $-0.39
- Dividend Yield
- 0.00%
Why Investors Own POAS
- βHigh-growth profile β revenue up +41.7% YoY with expanding US Equity exposure.
- βHealthy economics β 57% gross margin and 15% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About PHAOS TECHNOLOGY HOLDINGS-A
Phaos Technology Holdings (Cayman) Limited, operating through its Singapore-based subsidiary Phaos Technology Pte. Ltd., is a company focused on creating and commercializing sophisticated microscopy-related technologies, products, and solutions within Singapore. The company's product portfolio encompasses several specialized offerings: Optonano, which provides users with the ability to view both live and static images, enabling the assembly of high-quality visual data for larger sample regions. PT-Industrial, a versatile tool utilized across various applications including material analysis, fault identification, basic measurement tasks, quality control, inspection, and general manufacturing processes. PT-Metrology, which delivers accurate dimensional measurements through a straightforward, single-button operation. PT-Biology, designed to generate the specific types of imagery required by the biomedical field. PT-Stereo, a stereo microscope that produces crisp, magnified three-dimensional views, especially effective for examining solid or thicker samples. And PT-Zoom, which enhances visual understanding by providing a magnified 3D perspective of specimens. Beyond its hardware, the firm also furnishes specialized software. Its diverse clientele includes manufacturing enterprises, healthcare service providers in the biomedical sector, and various research and development organizations. Phaos Technology Holdings was founded in 2017 and maintains its corporate headquarters in Singapore.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
PHAOS TECHNOLOGY HOLDINGS-A tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift POAS price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
PHAOS TECHNOLOGY HOLDINGS-A announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.